Armata Pharmaceuticals, Inc.
US ˙ NYSEAM ˙ US04216R1023

Introduction

This page provides a comprehensive analysis of the known insider trading history of Vijay B Samant. Insiders are officers, directors, or significant investors in a company. It is illegal for insiders to make trades in their companies based on specific, non-public information. This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4. Despite these restrictions, academic research suggests that insiders - in general - tend to outperform the market in their own companies.

Average Trade Profitability

The average trade profitability is the average return of all the open market purchases made by the insider in the last three years. To calculate this, we examine every open-market, unplanned purchase made by the insider, excluding all trades that were marked as part of a 10b5-1 trading plan. We then calculate the average performance of those trades over 3, 6, and 12 months, averaging each of those durations to generate a final performance metric for each trade. Finally, we average all of the performance metrics to calculate a performance metric for the insider. This list only includes insiders that have made at least three trades in the last two years.

If this insiders trade profitability is "N/A", then the insider either has not made any open-market purchases in the last three years, or the trades they’ve made are too recent to calculate a reliable performance metric.

Update Frequency: Daily

See the list of most profitable insider traders.

Companies with Reported Insider Positions

The SEC filings indicate Vijay B Samant has reported holdings or trades in the following companies:

Security Title Latest Reported Holdings
US:BBI / Brickell Biotech Inc Director 65,000
US:APHB / Ampliphi Biosciences Corp. Director 10,900
US:RPTP / Raptor Pharmaceutical Corp. Director 70,000
How to Interpret the Charts

The following charts show the stock performance of securities subsequent to each open-market, non-planned trade made by Vijay B Samant. Non-planned trade are trades that were not made as part of a 10b5-1 trading plan. The stock performance is charted as cumulative percent change in share price. For example, if an insider trade was made on January 1, 2019, the chart will show the daily percent change of the security to the present day. If the share price were to go from $10 to $15 during this time, the cumulative percent change in share price would be 50%. A change in price from $10 to $20 would be 100%, and a change in price of $10 to $5 would be -50%.

Ultimately, we are trying to determine how closely the insider’s trades correlate to excess returns (positive or negative) in the share price in order to see if the insider is timing their trades to profit from insider information. Consider the situation where an insider was doing this. In this situation, we would expect either (a) positive returns after purchases, or (b) negative returns after sales. In the case of (a), the PURCHASE chart would show a series of upwardly sloping curves, indicating positive returns after each purchase transaction. In the case of (b), the SALE chart would show a series of downward sloping curves, indicating negative returns after each sale transaction.

However, this alone is not enough to draw conclusions. If, for example, the share price of the company was in a non-cyclical climb over many years, then we would expect all the post-purchase plots to be upwardly sloping. Likewise, non-cyclical declines over many years would result in downward sloping post-trade plots. Neither of these charts would suggest insider trading activity.

The strongest indicator would be a situation where the share price was extremely cyclical, and there were both positive signals in the PURCHASE chart and negative plots on the SALE chart. This situation would be highly suggestive of an insider that was timing trades to their financial advantage.

Insider Purchases ARMP / Armata Pharmaceuticals, Inc. - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made in ARMP / Armata Pharmaceuticals, Inc.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Max
Price at
Max
Max
Profit ($)
Max Return (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

ARMP / Armata Pharmaceuticals, Inc. Insider Trades
Insider Sales ARMP / Armata Pharmaceuticals, Inc. - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in ARMP / Armata Pharmaceuticals, Inc.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market sales that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Min
Price at
Min
Max Loss
Avoided ($)
Max Loss
Avoided (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

ARMP / Armata Pharmaceuticals, Inc. Insider Trades
Insider Trading History

This table shows the complete list of insider trades made by Vijay B Samant as disclosed to the Securities Exchange Commission (SEC).

File Date Tran Date Form Ticker Security Code 10b5-1 Shares Remaining Shares Percent
Change
Share
Price
Tran
Value
Remaining
Value
2022-05-17 2022-05-17 4 BBI Brickell Biotech, Inc.
Stock Option (right to buy)
A - Award 65,000 65,000
2021-06-14 2021-06-14 4 BBI Brickell Biotech, Inc.
Stock Option (right to buy)
A - Award 40,000 40,000
2021-01-05 2020-12-31 4 BBI Brickell Biotech, Inc.
Common Stock
F - Taxes -4,408 19,134 -18.72 0.78 -3,438 14,925
2020-09-17 2020-09-15 4 BBI Brickell Biotech, Inc.
Stock Option (right to buy)
A - Award 60,000 60,000
2020-09-17 2020-09-15 4 BBI Brickell Biotech, Inc.
Common Stock
A - Award 10,493 23,542 80.41 0.81 8,499 19,069
2020-09-02 2020-08-31 4 BBI Brickell Biotech, Inc.
Restricted Stock Units
M - Exercise -609 0 -100.00
2020-09-02 2020-08-31 4 BBI Brickell Biotech, Inc.
Common Stock
F - Taxes -6,375 13,049 -32.82 0.94 -5,992 12,266
2020-09-02 2020-08-31 4 BBI Brickell Biotech, Inc.
Common Stock
F - Taxes -256 19,424 -1.30 0.94 -241 18,259
2020-09-02 2020-08-31 4 BBI Brickell Biotech, Inc.
Common Stock
M - Exercise 609 19,680 3.19
2020-08-04 2020-07-31 4 BBI Brickell Biotech, Inc.
Restricted Stock Units
M - Exercise -608 609 -49.96
2020-08-04 2020-07-31 4 BBI Brickell Biotech, Inc.
Common Stock
F - Taxes -256 19,071 -1.32 0.92 -236 17,545
2020-08-04 2020-07-31 4 BBI Brickell Biotech, Inc.
Common Stock
M - Exercise 608 19,327 3.25
2020-07-02 2020-06-30 4 BBI Brickell Biotech, Inc.
Restricted Stock Units
M - Exercise -608 1,217 -33.32
2020-07-02 2020-06-30 4 BBI Brickell Biotech, Inc.
Common Stock
F - Taxes -256 18,719 -1.35 1.00 -256 18,719
2020-07-02 2020-06-30 4 BBI Brickell Biotech, Inc.
Common Stock
M - Exercise 608 18,975 3.31
2020-06-05 2020-06-03 4 BBI Brickell Biotech, Inc.
Stock Option (right to buy)
A - Award 4,333 4,333
2020-06-05 2020-06-03 4 BBI Brickell Biotech, Inc.
Common Stock
A - Award 15,178 18,367 475.95
2020-06-05 2020-05-31 4 BBI Brickell Biotech, Inc.
Restricted Stock Units
M - Exercise 608 608
2020-06-05 2020-05-31 4 BBI Brickell Biotech, Inc.
Common Stock
F - Taxes -256 3,189 -7.43 1.16 -297 3,699
2020-06-05 2020-05-31 4 BBI Brickell Biotech, Inc.
Common Stock
M - Exercise 608 3,445 21.43
2020-06-05 2020-04-30 4 BBI Brickell Biotech, Inc.
Restricted Stock Units
M - Exercise 609 609
2020-06-05 2020-04-30 4 BBI Brickell Biotech, Inc.
Common Stock
F - Taxes -256 2,837 -8.28 1.20 -307 3,404
2020-06-05 2020-04-30 4 BBI Brickell Biotech, Inc.
Common Stock
M - Exercise 609 3,093 24.52
2020-06-05 2020-03-31 4 BBI Brickell Biotech, Inc.
Restricted Stock Units
M - Exercise 608 608
2020-06-05 2020-03-31 4 BBI Brickell Biotech, Inc.
Common Stock
F - Taxes -256 2,484 -9.34 1.19 -305 2,956
2020-06-05 2020-03-31 4 BBI Brickell Biotech, Inc.
Common Stock
M - Exercise 608 2,740 28.52
2020-06-05 2020-02-29 4 BBI Brickell Biotech, Inc.
Restricted Stock Units
M - Exercise 608 608
2020-06-05 2020-02-29 4 BBI Brickell Biotech, Inc.
Common Stock
F - Taxes -256 2,132 -10.72 2.93 -750 6,247
2020-06-05 2020-02-29 4 BBI Brickell Biotech, Inc.
Common Stock
M - Exercise 608 2,388 34.16
2020-06-05 2020-02-14 4 BBI Brickell Biotech, Inc.
Restricted Stock Units
M - Exercise 3,070 3,070
2020-06-05 2020-02-14 4 BBI Brickell Biotech, Inc.
Common Stock
F - Taxes -1,290 1,780 -42.02 1.16 -1,496 2,065
2020-06-05 2020-02-14 4 BBI Brickell Biotech, Inc.
Common Stock
M - Exercise 3,070 3,070
2020-06-05 2020-02-14 4/A BBI Brickell Biotech, Inc.
Stock Options
A - Award 2,167 2,167
2020-06-05 2020-02-14 4/A BBI Brickell Biotech, Inc.
Restricted Stock Units
A - Award 7,328 7,328
2020-02-19 2020-02-14 4 BBI Brickell Biotech, Inc.
Stock Options
A - Award 7,328 7,328 1.16 8,500 8,500
2020-02-19 2020-02-14 4 BBI Brickell Biotech, Inc.
Restricted Stock Units
A - Award 2,167 2,167 1.16 2,514 2,514
2018-06-19 2018-06-18 4 VICL VICAL INC
Nonstatutory Stock Option (right to buy)
A - Award 105,000 105,000
2018-01-10 2018-01-08 4 VICL VICAL INC
Nonstatutory Stock Option (right to buy)
A - Award 36,775 36,775
2018-01-10 2018-01-08 4 VICL VICAL INC
Employee Stock Option (right to buy)
A - Award 68,225 68,225
2017-09-12 2017-09-07 4 APHB AmpliPhi Biosciences Corp
Stock Option (Right to Buy)
A - Award 10,900 10,900
2017-05-30 2017-05-25 4 VICL VICAL INC
Nonstatutory Stock Option (right to buy)
A - Award 25,000 25,000
2017-02-03 2017-02-01 4 VICL VICAL INC
Common Stock $.01 par value
S - Sale X -3,750 87,420 -4.11 2.16 -8,088 188,556
2017-01-17 2017-01-12 4 VICL VICAL INC
Nonstatutory Stock Option (right to buy)
A - Award 80,000 80,000
2017-01-17 2017-01-12 4 VICL VICAL INC
Nonstatutory Stock Option (right to buy)
A - Award 21,854 50,000 77.65
2017-01-17 2017-01-12 4 VICL VICAL INC
Employee Stock Option (right to buy)
A - Award 28,146 28,146
2017-01-12 2017-01-10 4 VICL VICAL INC
Common Stock $.01 par value
S - Sale X -5,763 91,170 -5.95 2.45 -14,114 223,284
2016-12-13 2016-12-13 4 VICL VICAL INC
Common Stock $.01 par value
S - Sale -4,649 96,933 -4.58 2.40 -11,172 232,949
2016-12-13 2016-12-12 4 VICL VICAL INC
Common Stock $.01 par value
S - Sale -11,050 101,582 -9.81 2.39 -26,415 242,832
2016-06-10 2016-06-09 4 VICL VICAL INC
Common Stock $.01 par value
P - Purchase 15,700 112,632 16.20 4.72 74,154 531,983
2016-05-24 2016-05-20 4 VICL VICAL INC
Nonstatutory Stock Option (right to buy)
A - Award 212,500 212,500
2016-03-03 2016-03-03 4 VICL VICAL INC
Common Stock $.01 par value
S - Sale X -5,900 969,326 -0.60 0.37 -2,199 361,268
2016-03-03 2016-03-02 4 VICL VICAL INC
Common Stock $.01 par value
S - Sale X -14,000 975,226 -1.42 0.37 -5,120 356,640
2016-03-03 2016-03-01 4 VICL VICAL INC
Common Stock $.01 par value
S - Sale X -17,600 989,226 -1.75 0.35 -6,237 350,582
2016-01-15 2016-01-15 4 VICL VICAL INC
Nonstatutory Stock Option (right to buy)
A - Award 199,244 425,000 88.26
2016-01-15 2016-01-15 4 VICL VICAL INC
Employee Stock Option (right to buy)
A - Award 225,756 225,756
2016-01-13 2016-01-12 4 VICL VICAL INC
Common Stock $.01 par value
S - Sale X -11,202 1,006,826 -1.10 0.35 -3,904 350,879
2016-01-13 2016-01-11 4 VICL VICAL INC
Common Stock $.01 par value
S - Sale X -48,535 1,018,028 -4.55 0.35 -16,856 353,561
2016-01-08 2016-01-07 4 VICL VICAL INC
Common Stock $.01 par value
S - Sale X -75,000 1,066,563 -6.57 0.36 -27,090 385,243
2015-11-09 2015-11-05 4 APHB AmpliPhi Biosciences Corp
Stock Option (Right to Buy)
A - Award 16,200 16,200
2015-10-14 2015-10-12 4 VICL VICAL INC
Common Stock $.01 par value
S - Sale X -4,738 1,141,563 -0.41 0.41 -1,962 472,607
2015-07-15 2015-07-13 4 VICL VICAL INC
Common Stock $.01 par value
S - Sale X -4,737 1,146,301 -0.41 0.70 -3,310 800,921
2015-05-26 2015-05-21 4 VICL VICAL INC
Nonstatutory Stock Option (right to buy)
A - Award 125,000 125,000
2015-04-15 2015-04-13 4 VICL VICAL INC
Common Stock $.01 par value
S - Sale X -4,738 1,151,038 -0.41 0.93 -4,411 1,071,616
2015-04-01 2015-03-30 4 VICL VICAL INC
Common Stock $.01 par value
S - Sale X -55,000 1,155,776 -4.54 0.91 -50,149 1,053,837
2015-01-21 2015-01-19 4 VICL VICAL INC
Nonstatutory Stock Option (right to buy)
A - Award 171,606 250,000 218.90
2015-01-21 2015-01-19 4 VICL VICAL INC
Employee Stock Option (right to buy)
A - Award 78,394 78,394
2015-01-21 2015-01-19 4 VICL VICAL INC
Common Stock $.01 par value
A - Award 300,000 1,210,776 32.94 0.01 3,000 12,108
2015-01-14 2015-01-13 4 VICL VICAL INC
Common Stock $.01 par value
S - Sale X -4,737 910,776 -0.52 1.12 -5,312 1,021,344
2014-12-29 2014-12-26 4 VICL VICAL INC
Common Stock
G - Gift -5,300 915,513 -0.58
2014-12-23 2014-12-23 4 VICL VICAL INC
Common Stock
G - Gift -321 920,813 -0.03
2014-12-23 2014-12-22 4 VICL VICAL INC
Common Stock
G - Gift -15,379 921,134 -1.64
2014-12-18 2014-12-18 4 VICL VICAL INC
Nonstatutory Stock Option (right to buy)
A - Award 175,000 175,000
2014-10-14 2014-10-13 4 VICL VICAL INC
Common Stock $.01 par value
S - Sale X -4,738 936,513 -0.50 1.13 -5,353 1,058,072
2014-07-15 2014-07-14 4 VICL VICAL INC
Common Stock $.01 par value
S - Sale X -4,737 941,251 -0.50 1.17 -5,544 1,101,546
2014-04-15 2014-04-14 4 VICL VICAL INC
Common Stock $.01 par value
S - Sale X -4,738 945,988 -0.50 1.16 -5,518 1,101,698
2014-04-09 2014-04-07 4 RPTP Raptor Pharmaceutical Corp
Stock options (right to buy)
M - Exercise X -5,000 70,000 -6.67
2014-04-09 2014-04-07 4 RPTP Raptor Pharmaceutical Corp
Common Stock
S - Sale X -5,000 0 -100.00 8.59 -42,958
2014-04-09 2014-04-07 4 RPTP Raptor Pharmaceutical Corp
Common Stock
M - Exercise X 5,000 5,000 3.33 16,650 16,650
2014-02-11 2014-02-07 4 RPTP Raptor Pharmaceutical Corp
Stock options (right to buy)
A - Award -50,000 50,000 -50.00
2014-02-11 2014-02-07 4 RPTP Raptor Pharmaceutical Corp
Stock options (right to buy)
M - Exercise X -5,000 0 -100.00
2014-02-11 2014-02-07 4 RPTP Raptor Pharmaceutical Corp
Common Stock
S - Sale X -5,000 0 -100.00 15.04 -75,212
2014-02-11 2014-02-07 4 RPTP Raptor Pharmaceutical Corp
Common Stock
M - Exercise X 5,000 5,000 5.13 25,650 25,650
2014-01-15 2014-01-10 4/A VICL VICAL INC
Common Stock $.01 par value
A - Award 330,000 950,726 53.16 0.01 3,300 9,507
2014-01-14 2014-01-13 4 VICL VICAL INC
Common Stock $.01 par value
F - Taxes -1,464 950,726 -0.15 1.34 -1,962 1,273,973
2014-01-14 2014-01-11 4 VICL VICAL INC
Common Stock $.01 par value
F - Taxes -7,398 952,190 -0.77 1.42 -10,505 1,352,110
2014-01-14 2014-01-11 4 VICL VICAL INC
Common Stock $.01 par value
F - Taxes -2,623 959,588 -0.27 1.42 -3,725 1,362,615
2014-01-14 2014-01-10 4 VICL VICAL INC
Nonstatutory Stock Option (right to buy)
A - Award 500,000 2,809,000 21.65
2014-01-14 2014-01-10 4 VICL VICAL INC
Common Stock $.01 par value
P - Purchase 330,000 962,211 52.20 1.42 468,600 1,366,340
2013-12-10 2013-12-09 4 RPTP Raptor Pharmaceutical Corp
Stock options (right to buy)
M - Exercise X -5,000 5,000 -50.00
2013-12-10 2013-12-09 4 RPTP Raptor Pharmaceutical Corp
Common Stock
S - Sale X -5,000 0 -100.00 13.86 -69,310
2013-12-10 2013-12-09 4 RPTP Raptor Pharmaceutical Corp
Common Stock
M - Exercise X 5,000 5,000 5.13 25,650 25,650
2013-10-15 2013-10-13 4 VICL VICAL INC
Common Stock $.01 par value
F - Taxes -1,463 632,211 -0.23 1.29 -1,887 815,552
2013-10-11 2013-10-11 4 VICL VICAL INC
Common Stock $.01 par value
F - Taxes -2,621 633,674 -0.41 1.29 -3,381 817,439
2013-10-09 2013-10-07 4 RPTP Raptor Pharmaceutical Corp
Stock options (right to buy)
M - Exercise X -5,000 10,000 -33.33
2013-10-09 2013-10-07 4 RPTP Raptor Pharmaceutical Corp
Common Stock
S - Sale X -5,000 0 -100.00 14.76 -73,802
2013-10-09 2013-10-07 4 RPTP Raptor Pharmaceutical Corp
Common Stock
M - Exercise X 5,000 5,000 5.13 25,650 25,650
2013-08-07 2013-08-05 4 VICL VICAL INC
Common Stock
G - Gift -1,400 636,295 -0.22
2013-07-15 2013-07-13 4 VICL VICAL INC
Common Stock $.01 par value
F - Taxes -1,471 637,695 -0.23 3.73 -5,487 2,378,602
2013-07-15 2013-07-11 4 VICL VICAL INC
Common Stock $.01 par value
F - Taxes -2,635 639,166 -0.41 3.72 -9,802 2,377,698
2013-04-15 2013-04-13 4 VICL VICAL INC
Common Stock $.01 par value
F - Taxes -1,471 641,801 -0.23 4.13 -6,075 2,650,638
2013-04-15 2013-04-11 4 VICL VICAL INC
Common Stock $.01 par value
F - Taxes -2,635 643,272 -0.41 4.10 -10,804 2,637,415
2013-01-15 2013-01-13 4 VICL VICAL INC
Common Stock $.01 par value
F - Taxes -5,883 645,907 -0.90 3.31 -19,473 2,137,952
2013-01-15 2013-01-11 4 VICL VICAL INC
Nonstatutory Stock Option (right to buy)
A - Award 446,750 2,459,000 22.20
2013-01-15 2013-01-11 4 VICL VICAL INC
Employee Stock Option (right to buy)
A - Award 35,250 2,012,250 1.78
2013-01-15 2013-01-11 4 VICL VICAL INC
Common Stock $.01 par value
F - Taxes -2,634 651,790 -0.40 3.31 -8,719 2,157,425
2013-01-15 2013-01-11 4 VICL VICAL INC
Common Stock $.01 par value
P - Purchase 84,600 654,424 14.85 0.01 846 6,544
2012-11-28 2012-11-19 4 VICL VICAL INC
Common Stock
G - Gift -5,000 569,824 -0.87
2012-10-11 2012-10-11 4 VICL VICAL INC
Common Stock $.01 par value
F - Taxes -2,635 574,824 -0.46 4.05 -10,672 2,328,037
2012-09-27 2012-09-25 4 RPTP Raptor Pharmaceutical Corp
Stock options (right to buy)
A - Award 50,000 230,000 27.78
2012-07-11 2012-07-11 4 VICL VICAL INC
Common Stock $.01 par value
F - Taxes -2,634 577,459 -0.45 3.55 -9,351 2,049,979
2012-04-12 2012-04-11 4 VICL VICAL INC
Common Stock $.01 par value
F - Taxes -2,633 580,093 -0.45 3.14 -8,268 1,821,492
2012-01-18 2012-01-13 4 VICL VICAL INC
Nonstatutory Stock Option (right to buy)
A - Award 328,527 2,102,000 18.52
2012-01-18 2012-01-13 4 VICL VICAL INC
Employee Stock Option (right to buy)
A - Award 33,473 1,773,473 1.92
2012-01-18 2012-01-13 4 VICL VICAL INC
Common Stock $.01 par value
P - Purchase 67,000 582,726 12.99 0.01 670 5,827
2012-01-12 2012-01-11 4 VICL VICAL INC
Common Stock $.01 par value
F - Taxes -2,635 515,726 -0.51 3.76 -9,908 1,939,130
2010-01-06 2010-01-06 4 VICL VICAL INC
Common Stock $.01 par value
F - Taxes -439 264,415 -0.17 3.28 -1,440 867,281
2010-01-06 2010-01-05 4 VICL VICAL INC
Common Stock $.01 par value
F - Taxes -658 264,854 -0.25 3.33 -2,191 881,964
2005-02-28 2005-02-22 4 VICL VICAL INC
Nonstatutory Stock Option (right to buy)
A - Award 58,441 58,441
2005-02-28 2005-02-22 4 VICL VICAL INC
Employee Stock Option (right to buy)
A - Award 16,559 16,559
2005-02-28 2005-02-22 4 VICL VICAL INC
Common Stock $.01 par value
A - Award 80,000 142,000 129.03 0.01 800 1,420
2004-11-02 2004-11-01 4 VICL VICAL INC
Common Stock $.01 par value
P - Purchase X 1,000 61,000 1.67 5.00 5,000 305,000
P
Open market or private purchase of non-derivative or derivative security
S
Open market or private sale of non-derivative or derivative security
A
Grant, award, or other acquisition of securities from the company (such as an option)
C
Conversion of derivative
D
Sale or transfer of securities back to the company
F
Payment of exercise price or tax liability using portion of securities received from the company
G
Gift of securities by or to the insider
K
Equity swaps and similar hedging transactions
M
Exercise or conversion of derivative security received from the company (such as an option)
V
A transaction voluntarily reported on Form 4
J
Other (accompanied by a footnote describing the transaction)